Epiminder Limited (ASX:EPI)

Australia · Delayed Price · Currency is AUD

0.580

-0.040 (-6.45%)

At close: Apr 28, 2026

-61.07% (1Y)

Market Cap	125.49M
Revenue (ttm)	648.18K
Net Income (ttm)	-38.14M
Shares Out	216.35M
EPS (ttm)	-0.44
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,840
Average Volume	59,681
Open	0.600
Previous Close	0.620
Day's Range	0.580 - 0.600
52-Week Range	0.455 - 1.490
Beta	n/a
RSI	46.58
Earnings Date	Aug 31, 2026

About Epiminder

Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company’s Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wireles... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol EPI

Full Company Profile

Financial Performance

In fiscal year 2025, Epiminder's revenue was 445,183, a decrease of -91.52% compared to the previous year's 5.25 million. Losses were -31.78 million, 91.5% more than in 2024.

Financial Statements

News

There is no news available yet.